This article discusses how to foster innovation within and across the Medical Affairs landscape, empower teams to deliver the best outcomes for patients and revolutionize healthcare delivery.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.
A Q&A on how Medical Affairs can align on omnichannel for long-term success
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, we sat down with Ruth Nicholson, Director, Global Knowledge Transfer (Neuroscience), Ipsen about the definition, challenges and emerging issues in knowledge transfer.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS Director, Mary Alice Dwyer, speaks with amir Shamim Choudry, Executive Medical Director at Sage Therapeutics, about the Single Point of Contact Model for Medical Affairs.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Bill Tidwell, Director, Field Based Medicine | Health System and Payor Strategy at Boehringer Ingelheim about engaging organized customers.
Advisory boards bring together a selection of key opinion leaders to discuss a topic important to a life sciences company. Here is how to use engagement technologies to generate actionable insights from your next ad board.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Robin Winter-Sperry and Robert Kersting, PharmD, Global Head, Scientific Alliances, Novartis, about the need for multi-stakeholder partnerships.
By using the framework of Explore, Educate, Embrace we can shape our approach to Health Equity by incorporating it into our daily work.